Gemfibrozil Tablet
Product Images NDC 70771-1431

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 70771-1431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (2f3cb828 6ff1 428d 99c7 Edb835d25d10 01)

Structure (2f3cb828 6ff1 428d 99c7 Edb835d25d10 01)
Chemical structure of gemfibrozil showing its molecular framework including a benzene ring with methyl groups and a propanoic acid side chain.*
FDA Label Image

Label (2f3cb828 6ff1 428d 99c7 Edb835d25d10 02)

Label (2f3cb828 6ff1 428d 99c7 Edb835d25d10 02)
Label for Gemfibrozil Tablets, USP 600 mg oral tablets by Zydus Lifesciences Limited. The label shows NDC 70771-1431-3 and indicates a 30-tablet container. Storage instructions specify 20° to 25°C and protection from light and humidity. It notes the product is Rx only and includes manufacturer location in Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.